在 BALB/c 小鼠模型中,接种 PIRES2-EGFP/CTB-UreI 疫苗可激活 Th1/Th2/Th17 混合免疫系统防御幽门螺旋杆菌感染。

Sana Ghasemifar, Omid Chabak, Tohid Piri-Gharaghie, Abbas Doosti
{"title":"在 BALB/c 小鼠模型中,接种 PIRES2-EGFP/CTB-UreI 疫苗可激活 Th1/Th2/Th17 混合免疫系统防御幽门螺旋杆菌感染。","authors":"Sana Ghasemifar, Omid Chabak, Tohid Piri-Gharaghie, Abbas Doosti","doi":"10.1016/j.vaccine.2024.02.050","DOIUrl":null,"url":null,"abstract":"<p><p>This article has been withdrawn at the request of the Editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal. The data presented in the manuscript was deemed severely flawed after appearing online as an Article in Press. The scientific community raised concerns about the methodology (including but not limited to major technical issues) used in the study and the subsequent conclusions drawn from the presented experiments. After careful investigation, the Vaccine editorial office concluded that the data in the publication was indeed severely flawed and that the concerns raised by the scientific community were valid. Therefore, the journal editors decided to withdraw the article and sincerely apologize for any inconvenience caused.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":" ","pages":"125733"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"WITHDRAWN: PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model.\",\"authors\":\"Sana Ghasemifar, Omid Chabak, Tohid Piri-Gharaghie, Abbas Doosti\",\"doi\":\"10.1016/j.vaccine.2024.02.050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This article has been withdrawn at the request of the Editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal. The data presented in the manuscript was deemed severely flawed after appearing online as an Article in Press. The scientific community raised concerns about the methodology (including but not limited to major technical issues) used in the study and the subsequent conclusions drawn from the presented experiments. After careful investigation, the Vaccine editorial office concluded that the data in the publication was indeed severely flawed and that the concerns raised by the scientific community were valid. Therefore, the journal editors decided to withdraw the article and sincerely apologize for any inconvenience caused.</p>\",\"PeriodicalId\":94264,\"journal\":{\"name\":\"Vaccine\",\"volume\":\" \",\"pages\":\"125733\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.vaccine.2024.02.050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.vaccine.2024.02.050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

人类胃炎、胃溃疡、远端胃癌和胃黏膜淋巴瘤的发生与幽门螺旋杆菌(H. pylori)密切相关。由于抗生素耐药性日益普遍,接种疫苗是一种有效的预防措施。融合疫苗接种是一种潜在的实用方法。本研究将霍乱毒素 B 亚基(CTB)与抗原性幽门螺杆菌尿素酶 I 亚基(CTB-UreI)结合,制成了一种融合疫苗。CTB-UreI DNA疫苗被化学克隆到pIRES2-EGFP中,并通过PCR和限制性酶消化验证了克隆的成功。对 CTB-UreI 在大肠杆菌 BL21(DE3) 中的诱导进行了研究。在 BALB/c 小鼠中评估了疫苗的免疫原性和免疫保护效力。Western 印迹检测成功确定了 CTB-UreI 的活化。相比之下,接种 pIRES2-EGFP/CTB-UreI 疫苗的 BALB/c 小鼠血液样本中的 IgG、IgA、IFN-γ、IL-4 和 IL-17 水平更高。此外,胃损伤和细菌负荷也有所减少。此外,接种了 pIRES2-EGFP/CTB-UreI 的 BALB/c 小鼠对幽门螺杆菌的挑战表现出了高水平的免疫力(100%)。pIRES2-EGFP/CTB-UreI引起了Th1/Th2/Th17组合免疫反应,可能有助于形成有效的防御机制。我们的数据表明,使用这种融合疫苗预防幽门螺杆菌感染是一种很有前景的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
WITHDRAWN: PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model.

This article has been withdrawn at the request of the Editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal. The data presented in the manuscript was deemed severely flawed after appearing online as an Article in Press. The scientific community raised concerns about the methodology (including but not limited to major technical issues) used in the study and the subsequent conclusions drawn from the presented experiments. After careful investigation, the Vaccine editorial office concluded that the data in the publication was indeed severely flawed and that the concerns raised by the scientific community were valid. Therefore, the journal editors decided to withdraw the article and sincerely apologize for any inconvenience caused.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信